Cargando…
The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014512/ https://www.ncbi.nlm.nih.gov/pubmed/31898736 http://dx.doi.org/10.1093/eurheartj/ehz916 |
_version_ | 1783673563058798592 |
---|---|
author | McMurray, John J V Solomon, Scott D Docherty, Kieran F Jhund, Pardeep S |
author_facet | McMurray, John J V Solomon, Scott D Docherty, Kieran F Jhund, Pardeep S |
author_sort | McMurray, John J V |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8014512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-80145122021-04-07 The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context McMurray, John J V Solomon, Scott D Docherty, Kieran F Jhund, Pardeep S Eur Heart J Viewpoint Oxford University Press 2020-05-07 /pmc/articles/PMC8014512/ /pubmed/31898736 http://dx.doi.org/10.1093/eurheartj/ehz916 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Viewpoint McMurray, John J V Solomon, Scott D Docherty, Kieran F Jhund, Pardeep S The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context |
title | The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context |
title_full | The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context |
title_fullStr | The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context |
title_full_unstemmed | The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context |
title_short | The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context |
title_sort | dapagliflozin and prevention of adverse outcomes in heart failure trial (dapa-hf) in context |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014512/ https://www.ncbi.nlm.nih.gov/pubmed/31898736 http://dx.doi.org/10.1093/eurheartj/ehz916 |
work_keys_str_mv | AT mcmurrayjohnjv thedapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext AT solomonscottd thedapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext AT dochertykieranf thedapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext AT jhundpardeeps thedapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext AT mcmurrayjohnjv dapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext AT solomonscottd dapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext AT dochertykieranf dapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext AT jhundpardeeps dapagliflozinandpreventionofadverseoutcomesinheartfailuretrialdapahfincontext |